What Researchers Did
Researchers conducted a prospective, randomized, blinded, multicenter, controlled trial to compare transdermal continuous oxygen therapy (TCOT) with a sham device, both in addition to moist wound therapy (MWT), for treating non-healing diabetic foot ulcers.
What They Found
The provided abstract details the study's methodology and primary endpoint, which was complete wound closure by week 12. However, the specific numerical findings and results comparing transdermal continuous oxygen therapy to the sham device are not included in the provided text.
What This Means for Canadian Patients
If transdermal continuous oxygen therapy proves effective, it could offer Canadian patients with non-healing diabetic foot ulcers an additional non-invasive treatment option to improve wound healing. This could potentially reduce complications and improve quality of life for those struggling with chronic wounds.
Canadian Relevance
This study was not conducted in Canada and does not have a direct Canadian connection.
Study Limitations
The 12-week study duration might not fully capture long-term healing maintenance or recurrence rates for diabetic foot ulcers.